USD0.000æéå€ååŒÂ  (ET)
32.48BæäŸ¡ç·é¡
12.79çŽè¿12ã¶æPER
äž»èŠããŒã¿
75.610å§å€
77.520é«å€
5.02Måºæ¥é«
12.79çŽè¿12ã¶æPER
10.73äºæ³PER
2.060çŽè¿12ã¶æé
åœ
1.19%売買å転ç
76.030忥çµå€
74.910å®å€
182.50M売買代é
13.07æ ªäŸ¡åçç
10.05PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
2.67%çŽè¿12ã¶æé
åœå©åã
18.07%ç·è³ç£å©çç
172.23052é±é«å€
1.00åºæ¥é«æ¯ç%
2.49BçŽå©ç
420.35Mæ ªåŒæ°
6.04191æ ªåœããå©çïŒEPSïŒ
0.77ããŒã¿å€
67.01%èªå·±è³æ¬å©çç
72.38052é±å®å€
3.43%æ¯ãå¹
70.29%ç²å©çç
32.48BæäŸ¡ç·é¡
1.02ãªã¹ã¯ãªã¿ãŒã³
1.61%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-31 äž»èŠã€ã³ãµã€ã
Zoetis Incã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå¥å
šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»è¬åæ¥çã§ã®é äœã¯155äž20äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯105.95ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžéãã¬ã³ããšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯å¹³åçã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Zoetis Incã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Zoetis Incã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
ææšî
ææš
売ã(1)
äžç«(5)
è²·ã(1)
ç§»åå¹³å
売ã(2)
äžç«(0)
è²·ã(4)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Zoetis Incã®äŒæ¥æ
å ±î
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
äŒæ¥ã³ãŒãZTS
äŒæ¥åZoetis Inc
æé«çµå¶è²¬ä»»è
ãCEOãPeck (Kristin C)
ãŠã§ããµã€ãhttps://www.zoetis.com/
æ ªäž»çµ±èšî
ãããã質å
Zoetis IncïŒZTSïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îZoetis IncïŒZTSïŒã®çŸåšã®æ ªäŸ¡ã¯77.28ã§ãã
Zoetis Incã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îZoetis Incã®ãã£ãã«ãŒã·ã³ãã«ã¯ZTSã§ãã
Zoetis Incã®52é±é«å€ã¯ãããã§ããïŒ
îZoetis Incã®52é±é«å€ã¯172.23ã§ãã
Zoetis Incã®52é±å®å€ã¯ãããã§ããïŒ
îZoetis Incã®52é±å®å€ã¯72.38ã§ãã
Zoetis Incã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îZoetis Incã®æäŸ¡ç·é¡ã¯32.48Bã§ãã
Zoetis Inc (ZTS) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãZoetis IncïŒZTSïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯105.95ã§ãã
Zoetis Inc (ZTS) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îZoetis IncïŒZTSïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯6.03ã§ãã